ECVT Ecovyst Inc.

FY2025 10-K
Filed: Feb 27, 2026
Health Care
Chemicals & Allied ProductsSEC EDGAR

Ecovyst Inc. (ECVT) filed its fiscal year 2025 10-K annual report with the SEC on Feb 27, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business model: integrated provider of virgin and regenerated sulfuric acid products and related services focused on refinery customers and industrial applications
  • Divested Advanced Materials & Catalysts segment for $556M, refocusing exclusively on sulfuric acid and related services
+3 more insights

Management Discussion & Analysis

  • Revenue $723.5M in 2025, up 20.9% YoY (+$125.2M) from $598.3M in 2024, driven by higher prices (+$97.9M) and sales volume (+$27.3M)
  • Operating margin declined to 9.0% in 2025 from 14.2% in 2024; operating income $64.9M vs $85.1M, down 23.7% due to higher costs and expenses
+3 more insights

Risk Factors

  • No specific or timely risks disclosed in the provided Risk Factors section of Ecovyst Inc.'s 2026 10-K filing

Get deeper insights on Ecovyst Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available